Intellectual property

We encourage commercial exploitation of the results from our funded research. 

This is primarily to ensure that we enhance the likelihood that research findings are translated more swiftly into patient benefit, in line with the practical aims of our mission:

“to play a leading role in the fight against disease of the heart and circulation, so that it is no longer a major cause of disability and premature death”. 

In addition, exploitation of our funded research has the potential to produce revenue for us that can be recycled into further research. 

All grant holders should be aware of the potential for protecting intellectual property (IP) and are encouraged to consider doing so at an early stage. Initial enquiries should be directed to their university technology transfer office. They should also keep us informed by email, quoting the grant reference number.

Our standard conditions on intellectual property (IP) and commercial exploitation are outlined in the standard conditions of grant. Written consent from the us is needed before IP is to be exploited or disposed of in any way. As a condition of granting such consent, we will require the institution to accept its standard revenue and equity sharing terms (available on request).